View source for 6fp9


==Crystal structure of anti-mTFP1 DARPin 1238_E11==
<StructureSection load='6fp9' size='340' side='right' caption='[[6fp9]], [[Resolution|resolution]] 2.10&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[6fp9]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Synthetic_construct_sequences Synthetic construct sequences]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6FP9 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6FP9 FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6fp9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6fp9 OCA], [http://pdbe.org/6fp9 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6fp9 RCSB], [http://www.ebi.ac.uk/pdbsum/6fp9 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6fp9 ProSAT]</span></td></tr>
</table>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Over the last few years, protein-based affinity reagents have proven very helpful in cell and developmental biology. While many of these versatile small proteins can be expressed both in the intracellular and extracellular milieu in cultured cells and in living organisms, they can also be functionalized by fusing them to different protein domains in order to regulate or modulate their target proteins in diverse manners. For example, protein binders have been employed to degrade, trap, localize or enzymatically modify specific target proteins. Whereas binders to many endogenous proteins or small protein tags have been generated, also several affinity reagents against fluorescent proteins have been created and used to manipulate target proteins tagged with the corresponding fluorescent protein. Both of these approaches have resulted in improved methods for cell biological and developmental studies. While binders against GFP and mCherry have been previously isolated and validated, we now report the generation and utilization of designed ankyrin repeat proteins (DARPins) against the monomeric teal fluorescent protein 1 (mTFP1). Here we use the generated DARPins to delocalize Rab proteins to the nuclear compartment, in which they cannot fulfill their regular functions anymore. In the future, such manipulations might enable the production of acute loss-of-function phenotypes in different cell types or living organisms based on direct protein manipulation rather than on genetic loss-of-function analyses.

DARPins recognizing mTFP1 as novel reagents for in vitro and in vivo protein manipulations.,Vigano MA, Bieli D, Schaefer JV, Jakob RP, Matsuda S, Maier T, Pluckthun A, Affolter M Biol Open. 2018 Sep 20. pii: bio.036749. doi: 10.1242/bio.036749. PMID:30237292<ref>PMID:30237292</ref>

From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 6fp9" style="background-color:#fffaf0;"></div>
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Synthetic construct sequences]]
[[Category: Affolter, M]]
[[Category: Bieli, D]]
[[Category: Jakob, R P]]
[[Category: Maier, T]]
[[Category: Matsuda, S]]
[[Category: Pluckthun, A]]
[[Category: Schaefer, J V]]
[[Category: Vigano, M A]]
[[Category: Darpin]]
[[Category: De novo protein]]
[[Category: Designed ankyrin repeat protein]]
[[Category: Protein binder]]